Anne Marie Nunes

Title: Anne Marie Nunes: Innovator in Neuropeptide Research

Introduction

Anne Marie Nunes is a prominent inventor based in Andover, MA (US). She has made significant contributions to the field of neuropeptide research, holding a total of 2 patents. Her work focuses on developing compounds that can effectively treat conditions associated with neuropeptide Y.

Latest Patents

One of her latest patents is titled "Benzimidzolyl neuropeptide Y receptor antagonists." This invention provides a series of substituted benzimidazoles that are useful in treating or preventing conditions associated with an excess of neuropeptide Y. The patent also outlines methods employing these substituted benzimidazoles, as well as pharmaceutical formulations that include one or more of these compounds as an active ingredient. Another significant patent is "Naphthimidazolyl neuropeptide Y receptor antagonists." This invention offers a series of substituted 1H-naphth-2,3-d!imidazoles that are beneficial in treating conditions related to an excess of neuropeptide Y. Similar to her previous patent, this one also provides methods and pharmaceutical formulations that utilize these compounds.

Career Highlights

Anne Marie Nunes is currently associated with Eli Lilly and Company, where she continues her innovative work in the pharmaceutical industry. Her research has the potential to impact the treatment of various health conditions, showcasing her dedication to advancing medical science.

Collaborations

Throughout her career, Anne has collaborated with notable colleagues, including Hamideh Zarrinmayeh and Thomas Charles Britton. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Anne Marie Nunes is a trailblazer in the field of neuropeptide research, with her patents paving the way for new therapeutic options. Her work at Eli Lilly and Company exemplifies her commitment to innovation and improving healthcare outcomes.